Spebrutinib (CC-292)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 03:32, 16 November 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Bruton's tyrosine kinase (BTK) inhibitor

Retrieved from "https://hemonc.org/w/index.php?title=Spebrutinib_(CC-292)&oldid=5752"